NCT03538171 2021-07-09Ph3 Study of Exemestane With or Without Entinostat in Chinese Patients With Hormone Receptor-Positive, Locally Advanced or Metastatic Breast CancerTaizhou EOC Pharma Co., Ltd.Phase 3 Unknown375 enrolled